1337 Ventures invests in Rebee Health to enhance remote physiotherapy services using wearable technology, addressing the rising demand for accessible rehabilitation solutions.
Target Information
Rebee Health is a pioneering startup focused on transforming the rehabilitation experience through the use of advanced wearable sensor technology. Its innovative physiotherapy system facilitates real-time, remote physiotherapy sessions, thereby enhancing accessibility and cost-efficiency in rehabilitation services. Central to Rebee's solution is a wearable sensor that captures biomechanical data from patients as they engage in exercises, fostering a data-driven approach to rehabilitation.
The data collected is transmitted to a user-friendly patient application, which provides immediate feedback on exercise performance, schedules, and progress tracking. Additionally, a dedicated therapist web portal allows healthcare providers to monitor patients remotely, leading to informed decision-making and diminished reliance on in-person consultations. This technological framework has the capacity to yield considerable savings for healthcare institutions, particularly in Singapore.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The rehabilitation industry globally is witnessing unprecedented growth fueled by an aging population that increasingly demands long-term care for chronic conditions, post-surgical rehabilit
Similar Deals
Kurma Partners, WE Life Sciences, Bpifrance, Argobio, Angelini Ventures, CARMA Fund, Capital Grand Est, Sambrinvest → Elkedonia
2025
1337 Ventures
invested in
Rebee Health
in
in a Seed Stage deal